Abstract: Disclosed are 6-(morpholinoalkyl)-substituted pyridines, and pharmaceutically acceptable salts and prodrugs thereof, that are active against a range of mammalian therapeutic indications.
Type:
Application
Filed:
May 1, 2013
Publication date:
January 16, 2014
Applicants:
Arisaph Pharmaceuticals
Inventors:
William W. Bachovchin, Hung-sen Lai, Daniel Philip O'Connell, Wengen Wu, Christopher P. Kiritsy